The Company is experiencing rising demand and increasing pipeline for the LIBERTY System since commencing the Full Market Release in ...
The Company is experiencing rising demand and increasing pipeline for the LIBERTY System since commencing the Full Market Release in April ...
Expanding manufacturing capabilities is part of the Company’s cost reduction strategy and supports global expansionHINGHAM, ...
The Company is experiencing rising demand and increasing pipeline for the LIBERTY System since commencing the Full Market Release in April Heightened awareness generating interest from leading health ...
The agreement with Lovell Government Services creates opportunities to sell the LIBERTY® System at more than 2,000 government facilities, including those administered by the U.S. Department of ...
Microbot Medical® Wins Surgical Robotics Industry Award for the LIBERTY® Endovascular Robotic System
Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY ® Endovascular Robotic System, announced that it has won the Innovative Start-Up Award from Surgical Robotics ...
Detailed price information for Microbot Medical Inc (MBOT-Q) from The Globe and Mail including charting and trades.
Detailed price information for Microbot Medical Inc (MBOT-Q) from The Globe and Mail including charting and trades.
First Midwest-based account reflects continued execution of the Company's Full Market Release strategy and expansion into additional U.S. territories ...
The agreement with Lovell Government Services creates opportunities to sell the LIBERTY® System at more than 2,000 government facilities, including those administered by the U.S. Department of ...
Leading academic center with multi-hospital and multi-state health system deepens Company’s footprint in the Northeast U.S. The Company now has multiple accounts and hospitals that have adopted the ...
Shares of electronics manufacturing services company Sanmina (NASDAQ:SANM) jumped 5.4% in the afternoon session after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results